ArticleJournal of cardiology cases2025
Phase analysis with heart risk view function for cardiac resynchronization therapy: A case report.
Article in Journal of cardiology cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocardial perfusion scintigraphy (MPS) is a valuable diagnostic tool for identifying stable angina and evaluating myocardial viability. In clinical practice, MPS-based analysis tools, such as the Heart Risk View (Nihon Medi-physics Co., Ltd., Tokyo, Japan), have proven effective in assessing left ventricular (LV) dyssynchrony. This case report illustrates the diagnostic utility of MPS in identifying and assessing LV dyssynchrony due to ventricular septal pacing for pacemaker implantation. Upon admission, the patient exhibited symptoms of heart failure (New York Heart Association Class II) due to a Wenckebach-type second-degree atrioventricular block, requiring dual-chamber pacemaker implantation with septal pacing. Eight months postoperatively, phase analysis using the Heart Risk View revealed a significantly reduced ejection fraction (EF: 30 %) and marked LV dyssynchrony [standard deviation width (PhSD): 86 degrees, histogram bandwidth (PhBW): 227 degrees]. Given the presentation of drug-resistant heart failure and asynchronous contraction, a cardiac resynchronization therapy (CRT) device was implanted. Immediately following CRT implantation, phase analysis demonstrated notable improvement in LV function (EF: 42 %) and LV dyssynchronous contraction (PhSD: 30 degrees, PhBW: 110 degrees). Learning objective: This study investigated the utility of myocardial perfusion scintigraphy in diagnosing post-implantation dyssynchronous contractions and assessing treatment efficacy. This case underscores the potential for dyssynchrony due to ventricular pacing. It emphasizes the importance of regular reassessment for mechanical dyssynchrony, particularly in patients experiencing a severe decline in ejection fraction or exercise tolerance following pacemaker implantation. Early evaluation is crucial to determine the need for cardiac resynchronization therapy and prevent further deterioration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.